Neuropathic pain: A practical guide for the clinician

CMAJ

Volumn 175, Issue 3, 2006, Pages 265-275

  Gilron, Ian ^a,b,d   Watson, C Peter N ^b   Cahill, Catherine M ^a   Moulin, Dwight E ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; BACLOFEN; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CARBAMAZEPINE; DEXTROMETHORPHAN; DOXEPIN; DULOXETINE; GABAPENTIN; KETAMINE; LAMOTRIGINE; LIDOCAINE; METHADONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN UPTAKE INHIBITOR; OPIATE; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; SEROTONIN; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADRENERGIC SYSTEM; AGRANULOCYTOSIS; ALGORITHM; ANESTHESIA; ANOREXIA; ANXIETY; APLASTIC ANEMIA; ATAXIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMPLEX REGIONAL PAIN SYNDROME; CONSERVATIVE TREATMENT; CONSTIPATION; DECOMPRESSION SURGERY; DEPRESSION; DIABETIC NEUROPATHY; DIARRHEA; DIPLOPIA; DISABILITY; DISEASE EXACERBATION; DOSE RESPONSE; EDEMA; ERYTHEMA; EXERCISE; FACILITATION; GAMMA KNIFE RADIOSURGERY; HEALTH CARE COST; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERHIDROSIS; HYPONATREMIA; IMAGERY; LIVER TOXICITY; META ANALYSIS; NAUSEA; NERVE EXCITABILITY; NEURALGIA; NEUROPATHIC PAIN; NONHUMAN; ORTHOSTATIC HYPOTENSION; PALLIATIVE THERAPY; PATIENT EDUCATION; PATIENT REFERRAL; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PSYCHOSIS; PSYCHOTHERAPY; RASH; RESPIRATION DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SEIZURE; SIDE EFFECT; SPINAL CORD STIMULATION; STEREOTAXIC SURGERY; STEVENS JOHNSON SYNDROME; SYMPATHETIC BLOCKING; SYSTEMATIC REVIEW; TRANSCUTANEOUS NERVE STIMULATION; TRIGEMINUS GANGLION; TRIGEMINUS NEURALGIA; UPREGULATION; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA; DRUG COMBINATION; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE;

ALGORITHMS; ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; DRUG THERAPY, COMBINATION; HUMANS; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PRIMARY HEALTH CARE;

EID: 33746792050     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060146     Document Type: Review

References (138)

1. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. In: Merskey H, Bogduk N, editors. Task force on taxonomy of the IASP. 2nd edition. Seattle: IASP Press; 1994, p. 209-14.
2. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain. Arch Neurol 2003;60:1524-34.
3. Boulton AJ, Armstrong WD, Scarpello JH, et al. The natural history of painful diabetic neuropathy - a 4-year study. Postgrad Med J 1983;59:556-9.
4. Max MB, Schafer SC, Culnane M, et al. Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 1988;43:363-71.
5. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 1998;5:209-27.
6. Jensen TS, Gottrup H, Sindrup SH, et al. The clinical picture of neuropathic pain. Eur J Pharmacol 2001;429:1-11.
7. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med 2003;348:1279-81.
8. Heliovaara M, Impivaara O, Sievers K, et al. Lumbar disc syndrome in Finland. J Epidemiol Community Health 1987;41:251-8.
9. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18:350-4.
10. Davis MP, Walsh D, Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care 2004;21:137-42.
11. Verma S, Estanislao L, Simpson D, HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs 2005;19:325-34.
12. Werhagen L, Budh CN, Hultling C, et al. Neuropathic pain after traumatic spinal cord injury-relations to gender, spinal level, completeness, and age at the time of injury. Spinal Cord 2004;42:665-73.
13. Sandroni P, Benrud-Larson LM, McClelland RL, et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003;103:199-207.
14. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-7.
15. Masson EA, Hunt L, Gem IM, et al. A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain 1989;38:25-8.
16. Gilron I, Bailey IM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-34.
17. Atlas SJ, Deyo RA, Patrick DL, et al. The Quebec Task Force classification for Spinal Disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis. Spine 1996;21:2885-92.
18. Coplan PM, Schmader K, Nikas A, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain 2004;5:344-56.
19. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143-9.
20. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002;18:355-65.
21. Galer B, Jensen M. Development and preliminary validation of a pain measure specific to neuropathic pain. The neuropathic pain scale. Neurology 1997;48:332-8.
22. Bennett M. The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 2001;92:147-57.
23. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain 2003;19:306-14.
24. Backonja MM, Krause SI. Neuropathic pain questionnaire - short form. Clin J Pain 2003;19:315-6.
25. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004;108:248-57.
26. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29-36.
27. Backonja MM, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin 1998;16:775-90.
28. Odrcich M, Bailey IM, Cahill CM, et al. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: Diurnal pain variation and effects of analgesic therapy. Pain 2006;120:207-12.
29. Smith MT, Haythornthwaite IA. How do sleep disturbance and chronic pain interrelate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004;8:119-32.
30. Haythornthwaite JA, Benrud-Larsen LM. Psychological aspects of neuropathic pain. Clin J Pain 2000;16:S101-5.
31. Smith MT, Edwards RR, Robinson RC, et al. Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased risk. Pain 2004;111:201-8.
32. Richeimer SH, Bajwa ZH, Kahraman SS, et al. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clin J Pain 1997;13:324-9.
33. Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage 2004;28:250-8.
34. Wilson P, Stanton-Hicks M, Harden RN, editors. CRPS: current diagnosis and therapy. [Volume 32 in Progress in pain research and management series]. Seattle: IASP Press; 1005.
35. Mendell JR, Sahenk Z. Clinical practice. Painful sensory neuropathy. N Engl J Med 2003;348:1243-55.
36. Kozin F, Soin JS, Ryan LM, et al. Bone scintigraphy in the reflex sympathetic dystrophy syndrome. Radiology 1981;138:437-43.
37. Sinnreich M, Taylor BV, Dyck PJ. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 2005;11:63-79.
38. Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999;107(2B):17S-26S.
39. Dyck PJ, Lambert EH, O'Brien PC. Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology 1976;26:466-71.
40. Attal N, Bouhassira D. Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand Suppl 1999;173:12-24.
41. Garfin SR, Rydevik B, Lind B, et al. Spinal nerve root compression. Spine 1995;20:1810-20.
42. Mulleman D, Mammou S, Griffoul I, et al. Pathophysiology of disk-related sciatica. I. Evidence supporting a chemical component. Joint Bone Spine 2006;73:151-8.
43. Oaklander AL. The pathology of shingles: Head and Campbell's 1900 monograph. Arch Neurol 1999;56:1292-4.
44. Watson CP, Deck JH, Morshead C, et al. Post-herpetic neuralgia: further postmortem studies of cases with and without pain. Pain 1991;44:105-17.
45. Brew BJ. The peripheral nerve complications of human immunodeficiency virus (HIV) infection. Muscle Nerve 2003;28:542-52.
46. Stanton-Hicks M, Janig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995;63:127-33.
47. Baron R, Levine ID, Fields HL. Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain? Muscle Nerve 1999;22:678-95.
48. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000;93:1123-33.
49. Alston RP, Pechon P. Dysaesthesia associated with stemotomy for heart surgery. Br J Anaesth 2005;95:153-8.
50. Walker K, Fox AJ, Urban LA. Animal models for pain research. Mol Med Today 1999;5:319-21.
51. Hansson PT, Dickenson AH. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 2005;113:251-4.
52. Devor M, Lomazov P, Matzner O. Sodium channel accumulation in injured axons as a substrate for neuropathic pain. In: Boivie J, Hansson P, Lindblom U, editors. Touch, temperature and pain in health and disease: mechanisms and assessments. [Volume 3 in Progress in pain research and management series.] Seattle: IASP Press; 1994. p. 207-30.
53. Wall PD, Gutnick M. Properties of afferent nerve impulses originating from a neuroma. Nature 1974;248:740-3.
54. Devor M. Neuropathic pain: what do we do with all these theories? Acta Anaesthesiol Scand 2001;45:1121-7.
55. Zhang J-M, Li H, Brull SJ. Perfusion of the mechanically compresed lumbar ganglion with lidocaine reduces mechanical hyperalgesia and allodynia in the rat. J Neurophysiol 2000;84:798-805.
56. Waxman SG, Cummins TR, Dib-Hajj S, et al. Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain. Muscle Nerve 1999;22:1177-87.
57. Matthews EA, Dickenson AH. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001;92:235-46.
58. White DM, Zimmermann M. The bradykinin-induced release of substance P from nerve fibre endings in the rat saphenous nerve neuroma is not related to electrophysiological excitation. Neurosci Lett 1988;92:108-13.
59. Luo ZD, Chaplan SR, Higuera ES, et al. Upreguladon of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001;21:1868-75.
60. Gilron I, Flatters SJL. Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence. Pain Res Manage 2006;11(Suppl A):16A-29A
61. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005;118:289-305.
62. Dickenson A, Matthews E, Suzuki R, Central nervous system mechanisms of pain in peripheral neuropathy. In: Hansson P, Fields H, Hill R, Marchettini P, editors. Neuropathic pain: pathophysiology and treatment. [Volume 21 in Progress in pain research and management series.] Seattle: IASP Press; 2001. p. 85-106.
63. Woolf CJ, Salter MW. Neuronal plasticity - increasing the gain in pain. Science 2000;288:1765-8.
64. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64.
65. Yaksh TL, Hua XY, Kalcheva I, et al. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci U S A 1999;96:7680-6.
66. Porreca F, Ossipov M, Gebhart G. Chronic pain and medullary descending facilitation. Trends Neurosci 2002;25:319-25.
67. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969;164:444-5.
68. Mayer DJ. Analgesia produced by electrical stimulation of the brain. Prog Neuropsychopharmacol Biol Psychiatry 1984;8:557-64.
69. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, editors. Textbook of pain. Edinburgh: Churchill Livingstone; 1999. p. 309-29.
70. Fields HL. Is there a facilitating component to central pain modulation? Am Pain Soc J 1992;1:71-8.
71. Chung K, Lee BH, Yoon YW, et al. Sympathetic sprouting in the dorsal root ganglia of the injured peripheral nerve in a rat neuropathic pain model. J Comp Neurol 1996;376:241-52.
72. Raja SN, Treede RD, Davis KD, et al. Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology 1991;74:691-8.
73. Koltzenburg M, McMahon SB. The enigmatic role of the sympathetic nervous system in chronic pain. Trends Pharmacol Sci 1991;12:399-402.
74. Chung K, Yoon YW, Chung JM. Sprouting sympathetic fibers form synaptic varicosities in the dorsal root ganglion of the rat with neuropathic injury. Brain Res 1997;751:275-80.
75. Grelik C, Bennett GJ, Ribeiro-da-Silva A. Autonomic fibre sprouting and changes in nociceptive sensory innervation in the rat lower lip skin following chronic constriction injury. Eur J Neurosci 2005;21:2475-87.
76. Sherry DD, Wallace CA, Kelley C, et al. Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy. Clin J Pain 1999;15:218-23.
77. Kumar D, Marshall HJ. Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 1997;20:1702-5.
78. Ghoname EA, White PF, Ahmed HE, et al. Percutaneous electrical nerve stimulation: an alternative to TENS in the management of sciatica. Pain 1999;83:193-9.
79. Moseley GL. Graded motor imagery is effective for long-standing complex regional pain syndrome: a randomised controlled trial. Pain 2004;108:192-8.
80. Evans S, Fishman B, Spielman L, et al. Randomized trial of cognitive behavior therapy versus supportive psychotherapy for HIV-related peripheral neuropathic pain. Psychosomatics 2003;44:44-50.
81. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
82. Stahl SM. Basic psychopharmacology of antidepressants, part I: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 1998;59(Suppl 4):5-14.
83. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
84. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-18.
85. Dogra S, Beydoun S, Mazzola J, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005;9:543-54.
86. Bryans JS, Wustrow DJ. 3-substituted GABA analogs with central nervous system activity: a review. Med Res Rev 1999;19:149-77.
87. Shneker BF, McAuley JW. Pregabalin: a new neuromodulator with broad therapeutic indications. Ann Pharmacother 2005;39:2029-37.
88. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA 2005;293:3043-52.
89. Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8.
90. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy, a randomized controlled trial. Neurology 2003;60:927-34.
91. Watson CP, Watt-Watson JH, Chipman ML. Chronic noncancer pain and the long term utility of opioids. Pain Res Manag 2004;9:19-24.
92. Harati Y, Gooch C, Swenson M, et al. Double blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-6.
93. Ebert B, Thorkildsen C, Andersen S, et al. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists. Biochem Pharmacol 1998;56:553-9.
94. Lynch ME. A review of the use of methadone for the treatment of chronic noncancer pain. Pain Res Manag 2005;10:133-44.
95. Gagnon B, Almahrezi A, Schreier G. Methadone in the treatment of neuropathic pain. Pain Res Manage 2003;8:149-54.
96. Morley JS, Bridson J, Nash TP, et al. Low dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med 2003;17:576-87.
97. Moulin DE, Palma D, Watling C, et al. Methadone in the management of intractable neuropathic noncancer pain. Can J Neurol Sci 2005;32:340-3.
98. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9.
99. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003;97:1730-9.
100. Sang CN, Booher S, Gilron I, et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002;96:1053-61.
101. Kang L, Jun HW. Formulation and efficacy studies of new topical anesthetic creams. Drug Dev Ind Pharm 2003;29:505-12.
102. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000;49:574-9.
103. Byas-Smith MG, Max MB, Muir J, et al. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage "enriched enrolment" design. Pain 1995;60:267-74.
104. Fromm GH, Terance CF, Charta AS. Baclofen in the treatment of trigeminal neuralgia. Ann Neurol 1984;15:240-7.
105. Cravatt BF, Lichtman AH. The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol 2004;61:149-60.
106. Svendsen KB, Jensen TS, Bach FW. The cannabinoid dronabinol reduces central pain in multiple sclerosis. A randomized double-blind placebo-controlled crossover trial. BMJ 2004;329:253-61.
107. Rog DJ, Nurmikko TJ, Friede T, et al. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005;65:812-9.
108. Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomized controlled trial. Pain 2004;112:299-306.
109. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
110. Rowbotham MC, Reisner LA, Davies PS, et al. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain 2005;6:741-6.
111. Watson CP, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51:1166-71.
112. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002;59:1015-21.
113. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-7.
114. Sindrup SH, Bach FW, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003;60:1284-9.
115. Gilron I, Bailey JM. Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials. Can J Anaesth 2003;50:42-7.
116. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Disease 2001;2:53-62.
117. Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 2000;16:188-92.
118. Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 2005;5:823-30.
119. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002;18:22-7.
120. Lopez BC, Hamlyn PJ, Zakrzewska JM. Systematic review of ablative neurosurgical techniques for the treatment of trigeminal neuralgia. Neurosurgery 2004;54:973-82.
121. Krames E. Implantable devices for pain control: spinal cord stimulation and intrathecal therapies. Best Pract Res Clin Anaesthesiol 2002;16:619-49.
122. Peng PW, Castano ED. Survey of chronic pain practice by anesthesiologists in Canada. Can J Anaesth 2005;52:383-9.
123. Gybels J, Erdine S, Maeyaert J, et al. Neuromodulation of pain. A consensus statement prepared in Brussels 16-18 January 1998 by the following task force of the European Federation of IASP Chapters (EFIC). Eur J Pain 1998;2:203-9.
124. Stanton-Hicks M, Baron R, Boas R, et al. Complex Regional Pain Syndromes: guidelines for therapy. Clin J Pain 1998;14:155-66.
125. Farrar JT, Young JP Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an II-point numerical pain rating scale. Pain 2001;94:149-58.
126. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996;11:203-17.
127. Jovey JD, Ennis J, Gardner-Nix J, et al. Use of opioid analgesics for the treatment of chronic noncancer pain - a consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 1998;3:197-222.
128. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-53.
129. American Pain Society. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Glenview, IL: The Society; 1997.
130. Virani A, Mailis A, Shapiro LE, et al. Drug interactions in human neuropathic pain pharmacotherapy. Pain 1997;73:3-13.
131. Max MB, Gilron I. Antidepressants, muscle relaxants, and NMDA receptor antagonists. In: Loeser JD, Turk D, Chapman CR, Butler S, editors. Bonica's management of pain. 3rd edition. Baltimore: Williams & Wilkins; 2001. p. 1710-26.
132. Gallagher RM. Neuropathic pain: the global challenge. Pain Med 2004;5(Suppl 1):S1-2.
133. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.
134. Fassoulaki A, Triga A, Melemeni A, et al. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg 2005;101:1427-32.
135. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995;122:561-8.
136. Belfer I, Wu T, Kingman A, et al. Candidate gene studies of human pain mechanisms: methods for optimizing choice of polymorphisms and sample size. Anesthesiology 2004;100:1562-72.
137. Thompson D. Toward a pharmacoeconomic model of neuropathic pain. Clin J Pain 2002;18:366-72.
138. Woolf CJ, Max MB. Mechanism-based pain diagnosis. Anesthesiology 2001;95:241-9.